ORIGINAL_ARTICLE
Decarboxylative cyanation and azidation of carboxylic acids: An overview
The present review gives an overview over the synthesis of organic nitriles and azides through the decarboxylative cyanation and azidation of carboxylic acids, respectively. Mechanistic features of the reactions are considered and discussed in detail.
https://www.chemrevlett.com/article_102860_41a8d0da942002aa0a1b4edc58713766.pdf
2020-01-01
2
8
10.22034/crl.2020.219565.1036
Decarboxylative functionalization
carboxylic acids
organic nitriles
organic azides
single electron transfer
Evan
Abdulkareem Mahmood
1
College of Health Sciences, University of Human Development, Sulaimaniyah, Kurdistan region of Iraq
AUTHOR
Bayan
Azizi
2
College of Health Sciences, University of Human Development, Sulaimaniyah, Kurdistan region of Iraq
AUTHOR
Soma
Majedi
soma.majedi@uhd.edu.iq
3
College of Health Sciences, University of Human Development, Sulaimaniyah, Kurdistan region of Iraq
LEAD_AUTHOR
[1] (a) F. Fleming, Nitrile-containing natural products, Nat. Prod. Rep, 16 (1999) 597-606; (b) F.F. Fleming, L. Yao, P. Ravikumar, L. Funk, B.C. Shook, Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophore, J. Med. Chem., 53 (2010) 7902-7917; (c) A. Kleemann, Pharmaceutical substances: Syntheses, Patents, Applications, 4th ed.; Thieme: Stuttgart, 2001.
1
[2] (a) J. Wang, F. Xu, T. Cai, Q. Shen, Addition of amines to nitriles catalyzed by ytterbium amides: An efficient one-step synthesis of monosubstituted N-arylamidines, Org. Lett., 10 (2008) 445-448; (b) T. Horneff, S. Chuprakov, N. Chernyak, V. Gevorgyan, V.V. Fokin, Rhodium-catalyzed transannulation of 1, 2, 3-triazoles with nitriles, J. Am. Chem. Soc., 130 (2008) 14972-14974; (c) S. Lu, J. Wang, X. Cao, X. Li, H. Gu, Selective synthesis of secondary amines from nitriles using Pt nanowires as a catalyst, Commun. Chem., 50 (2014) 3512-3515; (d) X. Wang, Y. Huang, Y. Xu, X. Tang, W. Wu, H. Jiang, Palladium-catalyzed denitrogenative synthesis of aryl ketones from arylhydrazines and nitriles using O2 as sole oxidant, J. Org. Chem., 82 (2017) 2211-2218.
2
[3] U. Dutta, D.W. Lupton, D. Maiti, Aryl nitriles from alkynes using tert-butyl nitrite: Metal-free approach to C-C bond cleavage, Org. Lett., 18 (2016) 860-863.
3
[4] (a) T. Cheng, Review of novel energetic polymers and binders–high energy propellant ingredients for the new space race, Des. Monomers Polym., 22 (2019) 54-65; (b) W.R. Martin, D.W. Ball, Small organic azides as high energy materials: Perazidoacetylene,‐ethylene, and‐allene, ChemistrySelect, 3 (2018) 7222-7225.
4
[5] (a) T.-S. Lin, W.H. Prusoff, Synthesis and biological activity of several amino analogs of thymidine, J. Med. Chem., 21 (1978) 109-112; (b) D.B. Smith, G. Kalayanov, C. Sund, A. Winqvist, T. Maltseva, V.J.-P. Leveque, S. Rajyaguru, S.L. Pogam, I. Najera, K. Benkestock, The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4′-azidocytidine against hepatitis C virus replication: the discovery of 4′-azido-2′-deoxy-2′-fluorocytidine and 4′-azido-2′-dideoxy-2′, 2′-difluorocytidine, J. Med. Chem., 52 (2009) 2971-2978; (c) J.A. Raeburn, J.D. Devine, Pharmacological findings during azidocillin treatment of chest infections, Scand. J. Infect. Dis., 5 (1973) 135-139; (d) P.P. Geurink, W.A. van der Linden, A.C. Mirabella, N. Gallastegui, G. de Bruin, A.E. Blom, M.J. Voges, E.D. Mock, B.I. Florea, G.A. van der Marel, Incorporation of non-natural amino acids improves cell permeability and potency of specific inhibitors of proteasome trypsin-like sites, J. Med. Chem., 56 (2013) 1262-1275.
5
[6] (a) N. Rodriguez, L.J. Goossen, Decarboxylative coupling reactions: a modern strategy for C–C-bond formation, Chem. Soc. Rev., 40 (2011) 5030-5048; (b) J. Schwarz, B. König, Decarboxylative reactions with and without light–a comparison, Green Chem., 20 (2018) 323-361.
6
[7] R. Shang, Transition metal-catalyzed decarboxylation and decarboxylative cross-couplings, in: New Carbon–Carbon Coupling Reactions Based on Decarboxylation and Iron-Catalyzed C–H Activation, Springer, 2017, pp. 3-47.
7
[8] (a) S. Arshadi, S. Ebrahimiasl, A. Hosseinian, A. Monfared, E. Vessally, Recent developments in decarboxylative cross-coupling reactions between carboxylic acids and N–H compounds, RSC Adv., 9 (2019) 8964-8976; (b) A. Monfared, S. Ebrahimiasl, M. Babazadeh, S. Arshadi, E. Vessally, Recent advances in decarboxylative trifluoromethyl (thiol) ation of carboxylic acids, J. Fluor. Chem., 220 (2019) 24-34; (c) A. Hosseinian, F.A.H. Nasab, S. Ahmadi, Z. Rahmani, E. Vessally, Decarboxylative cross-coupling reactions for P(O)–C bond formation, RSC Adv., 8 (2018) 26383-26398; (d) A. Hosseinian, P.D.K. Nezhad, S. Ahmadi, Z. Rahmani, A. Monfared, A walk around the decarboxylative C–S cross-coupling reactions, J. Sulfur Chem., 40 (2019) 88-112.
8
[9] D.A. Klein, Nitrile synthesis via the acid-nitrile exchange reaction, J. Org. Chem., 36 (1971) 3050-3051.
9
[10] D. Cantillo, C.O. Kappe, Direct preparation of nitriles from carboxylic acids in continuous flow, J. Org. Chem., 78 (2013) 10567-10571.
10
[11] D. Cartigny, A. Dos Santos, L. El Kaim, L. Grimaud, R. Jacquot, P. Marion, Nitrile synthesis through catalyzed cascades involving acid–nitrile exchange, Synthesis, 46 (2014) 1802-1806.
11
[12] D.H. Barton, J.C. Jaszberenyi, E.A. Theodorakis, The invention of radical reactions. Part XXIII new reactions: Nitrile and thiocyanate transfer to carbon radicals from sulfonyl cyanides and sulfonyl isothiocyanates, Tetrahedron, 48 (1992) 2613-2626.
12
[13] F. Le Vaillant, M.D. Wodrich, J. Waser, Room temperature decarboxylative cyanation of carboxylic acids using photoredox catalysis and cyanobenziodoxolones: a divergent mechanism compared to alkynylation, Chem. Sci., 8 (2017) 1790-1800.
13
[14] F.L. Vaillant, J. Waser, Decarboxylative alkynylation and cyanation of carboxylic acids using photoredox catalysis and hypervalent iodine reagents, Chimia, 71 (2017) 226-230.
14
[15] N.P. Ramirez, B. König, J.C. Gonzalez-Gomez, Decarboxylative cyanation of aliphatic carboxylic acids via visible-light flavin photocatalysis, Org. Lett., 21 (2019) 1368-1373.
15
[16] K. Ouchaou, D. Georgin, F. Taran, Straightforward conversion of arene carboxylic acids into aryl nitriles by palladium-catalyzed decarboxylative cyanation reaction, Synlett, (2010) 2083-2086.
16
[17] O. Loreau, D. Georgin, F. Taran, D. Audisio, Palladium‐catalyzed decarboxylative cyanation of aromatic carboxylic acids using [13C] and [14C]‐KCN, J. Label. Compd. Radiopharm., 58 (2015) 425-428.
17
[18] Z. Fu, Z. Li, Y. Song, R. Yang, Y. Liu, H. Cai, Decarboxylative halogenation and cyanation of electron-deficient aryl carboxylic acids via cu mediator as well as electron-rich ones through pd catalyst under aerobic conditions, J. Org. Chem., 81 (2016) 2794-2803.
18
[19] Z. Fu, L. Jiang, Z. Li, Y. Jiang, H. Cai, Ag/Cu-mediated decarboxylative cyanation of aryl carboxylic acids with K4Fe (CN) 6 under aerobic conditions, Synth. Commun., 49 (2019) 917-924.
19
[20] F. Song, R. Salter, L. Chen, Development of decarboxylative cyanation Reactions for C-13/C-14 carboxylic acid labeling using an electrophilic cyanating reagent, J. Org. Chem., 82 (2017) 3530-3537.
20
[21] E. Nyfeler, P. Renaud, Decarboxylative radical azidation using MPDOC and MMDOC esters, Org. Lett., 10 (2008) 985-988.
21
[22] C. Liu, X. Wang, Z. Li, L. Cui, C. Li, Silver-catalyzed decarboxylative radical azidation of aliphatic carboxylic acids in aqueous solution, J. Am. Chem. Soc., 137 (2015) 9820-9823.
22
[23] Y. Zhu, X. Li, X. Wang, X. Huang, T. Shen, Y. Zhang, X. Sun, M. Zou, S. Song, N. Jiao, Silver-catalyzed decarboxylative azidation of aliphatic carboxylic acids, Org. Lett., 17 (2015) 4702-4705.
23
[24] Z.C. Kennedy, C.A. Barrett, M.G. Warner, Direct functionalization of an acid-terminated nanodiamond with azide: enabling access to 4-substituted-1, 2, 3-triazole-functionalized particles, Langmuir, 33 (2017) 2790-2798.
24
[25] D.C. Marcote, R. Street-Jeakings, E. Dauncey, J.J. Douglas, A. Ruffoni, D. Leonori, Photoinduced decarboxylative azidation of cyclic amino acids, Org. Biomol. Chem., 17 (2019) 1839-1842.
25
ORIGINAL_ARTICLE
Could silver nano-particles control the 2019-nCoV virus?; An urgent glance to the past
2019-nCoV, this tiny crowned virus, which was first spread from Wuhan, China, killed thousands of peoples in China, Italy, Iran, and Spain, in a very short period of time. Now, it reaches to most countries all around the world, and thus, it becomes one of the most important threats against all human race. The fact is, the outbreak of this virus showed us, how much our science about the new viruses is weak and insufficient. In the near future, we have to revolutionary increase our knowledge about viruses and controlling those species. Due to the recent reports about the effect of silver nanoparticles (AgNPs) (in vitro and in vivo) on corona virus family especially influenzas, in this study, we have made attempts to take a glance on the effect of AgNPs on the viruses, and ask ourselves "may nano particles inhibit the 2019-nCoV?"
https://www.chemrevlett.com/article_105425_63cfdc26d04c7db7683cc2a11b0894be.pdf
2020-01-01
9
11
10.22034/crl.2020.224649.1044
: 2019-nCoV
corona virus
Outbreak
Nano-silver
virus inhibition
Seyyed Amir
Siadati
chemistry_2021@yahoo.com
1
Department of Chemistry, Qaemshahr Branch, Islamic Azad University, Qaemshahr, Iran
LEAD_AUTHOR
Mohsen
Afzali
tabibkhane@yahoo.com
2
No.702, Navab st, Azadi st, Tehran, (P.O.BOX: 14195-371) Iran
AUTHOR
Mehdi
Sayyadi
sayyadi_teb@yahoo.com
3
No.702, Navab st, Azadi st, Tehran, (P.O.BOX: 14195-371) Iran
AUTHOR
[1] S.L. Percival, P.G. Bowler, J. Dolman, Antimicrobial activity of silver containing dressings on wound microorganisms using an in vitro biofilm model, Int. Wound J 4 (2007) 186–191.
1
[2] A.R. Shahverdi, A. Fakhimi, H.R. Shahverdi, S. Minaian, Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli, Nanomedicine 3 (2007) 168–171.
2
[3] J.M. Nam, C.S. Thaxton, C.A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301 (2003) 1884–1886.
3
[4] J.P. Guggenbichler, M. Boswald, S. Lugauer, T. Krall, A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters, Infection 27 (1999) 16–23.
4
[5] I. Sondi, B. Salopek-Sondi, Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275 (2004) 177–182.
5
[6] J.L. Elechiguerra, J.L. Burt, J.R. Morones, A. Camacho-Bragado, X. Gao, H.H. Lara, M.J. Yacaman, Interaction of silver nanoparticles with HIV-1, J nanobiotechnology 3 (2005) 6.
6
[7] H.H. Lara, N.V. Ayala-Nunez, L. Ixtepan-Turrent, C. Rodriguez-Padilla, Mode of antiviral action of silver nanoparticles against HIV-1, J Nanobiotechnol., 8 (2010) 1.
7
[8] B. Borrego, G. Lorenzo, J.D. Mota-Morales, H. Almanza-Reyes, F. Mateos, E. López-Gil, ... & N. Bogdanchikova, Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo. Nanomedicine: NBM, 12 (2016) 1185-1192.
8
[9] L. Sun, A.K. Singh, K. Vig, S.R. Pillai, S.R. Singh, Silver nanoparticles inhibit replication of respiratory syncytial virus. J Biomed Biotechnol 4 (2008) 149–158.
9
[10] L. Lu, R.W. Sun, R. Chen, C.K. Hui, C.M. Ho, J.M. Luk, G.K. Lau, C.M. Che, Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther 13 (2008) 253–262.
10
[11] D.B. Pinto, S. Shukla, N. Perkas, A. Gedanken, R. Sarid, Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug Chem 20 (2009) 1497–1502.
11
[12] J.V. Rogers, C.V. Parkinson, Y.W. Choi, J.L. Speshock, S.M. Hussain, A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation, Nanoscale Res Lett 3 (2008) 129–133.
12
[13] D. Morris, M. Ansar, J. Speshock, T. Ivanciuc, Y. Qu, A. Casola, R.P. Garofalo, Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection. Viruses 11 (2019) 732.
13
[14] D.X. Xiang, Q. Chen, L. Pang, C.L. Zheng, Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J virol methods 178 (2011) 137-142.
14
[15] D. Xiang, Y. Zheng, W. Duan, X. Li, J. Yin, S. Shigdar, B. Xiang, Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J nanomedicine 8 (2013) 4103.
15
[16] S. Gaikwad, A. Ingle, A. Gade, M. Rai, A. Falanga, N. Incoronato, M. Galdiero, Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int. J nanomed., 8 (2013) 4303.
16
[17] C. You, C. Han, X. Wang, Y. Zheng, Q. Li, X. Hu, H. Sun, The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep 39 (2012) 9193-9201.
17
[18] D.J. Barillo, D.E. Marx, Silver in medicine: a brief history BC 335 to present. Burns 4 (2014) 3-8.
18
[19] D. K. Tiwari, J. Takashi, J. Behari, Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats, Toxicol. Mech. Methods, 21 (2011) 13-24.
19
[20] N. Hadrup, H.R. Lam, Oral toxicity of silver ions, silver nanoparticles and colloidal silver–a review. Regul Toxicol Pharmacol, 68 (2014) 1-7.
20
ORIGINAL_ARTICLE
QSAR and molecular docking study on the biological activity of levofloxacin and thiodiazole histone deacetylase inhibitors
Using quantitative structure-activity relationship (QSAR) and molecular docking to study the interaction between levofloxacin and thiadiazole histone deacetylase inhibitors. The molecular electrical distance vector (MEDV) and multiple linear regression (MLR) were used to study the relationship between the structure and activity of compounds. The three equations obtained by multiple linear regression, their R2 = 0.976, 0.985 and 0.976, and their Rcv2 = 0.949, 0.977 and 0.932. The structures that affect HDAC1 and HDAC6 activity are -O- and -S-, and the structures that affect HDAC2 are -C- and -N-. Finally, molecular docking is used to study the binding of receptors and drug molecules to provide guidance for future drug design.
https://www.chemrevlett.com/article_104078_8e3689fd840fcb4f0f8639646abe6c71.pdf
2020-01-01
12
18
10.22034/crl.2020.218151.1034
MEDV
MLR
Drug design
Zhong
Wan
zhongyuwanxzit@163.com
1
School of Chemistry and Chemical Engineering, Xuzhou Institute of Technology, Xuzhou, China
LEAD_AUTHOR
Rong
Sun
2
School of Foreign Languages, Xuzhou Institute of Technology, Xuzhou, China
AUTHOR
[1] I. A. Khan, S. Siddiqui and S. Rehmani, Fluoroquinolones inhibit HCV by targeting its helicase. Antivir. Ther., 17 (2012) 467-476.
1
[2] B. C. Smith and J. M. Denu, Chemical mechanisms of histone lysine and arginine modifications. Biochim. Biophys. Acta, 17 (2009) 45-57.
2
[3] M. J. Lai, H. L. Huang and S. L. Pan, Synthesis and biological evaluation of 1-arylsulfonyl-5-(N-hydroxyacrylamide) indoles as potent histone deacetylase inhibitors with antitumor activity in vivo. J. Med. Chem., 55 (2012) 3777-3791.
3
[4] F. F. Wagner, D. E. Olson, and J. P. Gale, Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif. J. Med. Chem., 56 (2013) 1772-1776.
4
[5] H. Y. Lee, A. C. Tsai and M. C. Chen, Azaindolyl sulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells. J. Med. Chem., 57 (2014) 4009-4022.
5
[6] C. Tang, C. H. Li and S. L. Zhang, Novel bioactive hybrid compound dual targeting estrogen receptor and histone deacetylase for the treatment of breast cancer. J. Med. Chem., 58 (2015) 4550-4572.
6
[7] Y. W. Yao, H. Q. Yao and S. Jiang, Progress in clinical study of histone deacetylases inhibitors as anticancer agents .Chin. J. New. Drugs., 22 (2013) 294-299.
7
[8] P. Guan, X. Hou and L. Wang, Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif. Bioorg. Med. Chem., 22 (2014) 5766−5775.
8
[9] Y. M. Tan, W. Y. Huang and N. F. Yu, Structure-activity relationships of histone deacetylase inhibitors. Acta Pharm. Sin., 44 (2009) 1072-1083.
9
[10] S. Q. Xie, and Y. S. Chen, Part IV. Synthesis and antitumor evaluation of s-triazolothiadiazines and pyrazolos-triazoles derived from criproxacin. Acta Pharm. Sin., 47 (2012) 66-71.
10
[11] L. Z. Gao Y. S. Xie and T. Li, Synthesis, antitumor activity and SAR of C-3 oxadiazole sulfanylacetyl hydrazone-substituted fluoroquinolone analogues. Acta Pharm. Sin., 49 (2014) 1694-1698.
11
[12] Y. Itoh, and T. Suzuki, Isoform-selective histonedeacetylase inhibitors. Curr. Pharm. Des., 14 (2008) 529-544.
12
[13] J. Senger, J. Melesina and M. Marek, Synthesis and biological investigation of oxazole hydroxamatesas highly selective histone deacetylase 6 (HDAC6) inhibitors. J. Med. Chem., 59 (2016) 1545-1555.
13
[14] J. K. Murray and C. Balan, Dipeptidylquinolone derivatives inhibit hypoxia inducible factor-1 prolyl hydroxylases-1, -2, and -3 with altered selectivity. J. Comb. Chem., 12 (2010) 676-686.
14
[15] X. L. Jiang, Y. B. Cui and S. H. Cao, Progress in research on quinolone antibacterials. Chin. J. Antibiot., 36 (2011) 255-263.
15
[16] H. Li, X. Han and D. W. Li, Synthesis and anti-tumor activity of levofloxacin-thiadiazole histone deacetylase inhibitor conjugates. Acta Pharm. Sinica, 52 (2017) 582-591.
16
[17] L. B. Kier and L. H. Hall, An electrotopological-state index for atoms in molecules. Pharm. Res., 7 (1990) 801-807.
17
ORIGINAL_ARTICLE
A mini-review on the current COVID-19 therapeutic strategies
The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for development of an effective drug therapy has attracted worldwide attention recently. So far, no certain cure or specific vaccine has been suggested by Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) to fight this deadly disease. However, several different treatment protocols have been proposed based on older drugs. Researchers around the world still attempt to evaluate them in clinical trials. In this mini review, we summarize the available drugs that have been used in the treatment of COVID-19 based on the existing guidelines.
https://www.chemrevlett.com/article_105675_b83a7fc889ce14e8ee1a4f6281ad3f2f.pdf
2020-01-01
19
22
10.22034/crl.2020.225263.1049
COVID-19
Coronavirus
Drug Treatment
Samira
Shafiee
1
Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
AUTHOR
Soodabeh
Davaran
davaran@tbzmed.ac.ir
2
Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
LEAD_AUTHOR
1] Z. Anna L, and Z. Robert M, Fractal kinetics of COVID-19 pandemic. medRxiv (2020).
1
[2] R. Qiurong, et al., Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive. Care. Med., 46 (2020) 846-848.
2
3] Organization, W.H., Coronavirus disease 2019 ( COVID-19): situation report 51(2020).
3
[4] C. Marco, et al., Features, Evaluation and Treatment Coronavirus (COVID-19), in StatPearls [Internet]. (2020) StatPearls Publishing.
4
[5] L. Xiaowei, et al., Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal., 10 (2020) 102-108.
5
[6] S. Catrin, et al., World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int. J. Surg., 76 (2020) 71-76.
6
[7] A Hussin, R. and B. Siddappa N, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun., 109 (2020) 102433.
7
[8] Y. Yongshi, et al., The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun., 109 (2020) 102434.
8
[9] P. Noah C, et al., The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int. J. Epidemiol., 49 (2020) 717-726.
9
[10] Z. Lei, and L. Yunhui, Potential interventions for novel coronavirus in China: A systematic review. J. Med. Virol., 92 (2020) 479-490.
10
[11] D. R. Carlos, and M. Preeti N, COVID-19—new insights on a rapidly changing epidemic. Jama., 323 (2020) 1341-1343.
11
[12] Z. Yadi, , et al., Network -based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell. Discov., 6 (2020) 1-18.
12
[13] W. Junmei, Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) Through Computational Drug Repurposing Study (2020).
13
[14] J. Zhenming, et al., Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19. Nature., (2020) DOI: 10.1101/2020.02.26.964882.
14
[15] A. E. Abdo, Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life. Sci., 248 (2020) 117477.
15
[16] S. Micholas, and S. Jeremy C, Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface., (2020) DOI: 10.26434/chemrxiv.11871402.v4.
16
[17] F. Ayman, et al., Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning. ChemRxiv., (2020) DOI: 10.26434/chemrxiv.12049647.v1.
17
[18] G. Yiyue, et al., A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. BioRxiv., (2020) DOI: 10.1101/2020.03.11.986836.
18
[19] S. Balamurugan, et al., Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian. Pac. J. Allergy. Immunol., 38 (2020) 10-18.
19
[20] W. Manli, et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell. Res., 30 (2020) 269-271.
20
[21] G. Philippe, et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents., 56 (2020)105949.
21
[22] V. Thirumalaisamy P, and M. Christian G, The COVID-19 epidemic. Trop. Med. Int. Health., 25 (2020) 278-280.
22
[23] S. Tanu, A Review of Coronavirus Disease-2019 (COVID-19). Indian. J. Pediatr., 87 (2020) 281-286
23
[24] C. Wei, et al. High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019. Open. Forum. Infect. Dis., 7 (2020) ofaa102.
24
[25] K. Kai, and C. Jon, Race to find COVID-19 treatments accelerates. Sci., 367 (2020) 1412-1413.
25
[26] T. Janice Hopkins, Covid-19: FDA approves use of convalescent plasma to treat critically ill patients. B. M. J., 368) 2020 .( m1256
26
[27] D. Liying, H. Shasha, and G. Jianjun, Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug. Discov. Ther., 14 (2020) 58-60.
27
[28] A. MHB, Need to test Azithromycin as first-line therapy for Covid-19.
28
[29] L. Caly, et al., The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir. Res., 178 (2020) 104787.
29
ORIGINAL_ARTICLE
Theoretical insights into the intermolecular and mechanisms of covalent interaction of Flutamide drug with COOH and COCl functionalized carbon nanotubes: A DFT approach
In this study, it is attempted to scrutinize the noncovalent interaction and two mechanisms of covalent between Flutamide anti-cancer drug (FLU) and functionalized carbon nanotubes (f-CNT) employing density functional theory (DFT) calculations regarding their geometries, binding energies and topological features of the electron density in the water solution. For designed noncovalent interactions, binding energies, natural bond orbital (NBO), atom in molecule (AIM) and quantum molecular descriptors analyses were applied for further understanding of the adsorption process. The computed theoretical results confirmed that binding of Flutamide molecule with functionalized CNT is thermodynamically suitable and among two considered systems containing COOH functionalized CNT (NTCOOH) and COCl functionalized CNT (NTCOCl), the NTCOOH revealed more binding energy value which suggests it as a favorable system as a drug delivery within biological and chemical systems (noncovalent). NTCOOH and NTCOCl can bond to the NH group of flutamide through OH (COOH mechanism) and Cl (COCl mechanism) groups, respectively. Finally, to obtain the values of activation energies, the activation enthalpies and the activation Gibbs free energies of two considered pathways different calculations were performed and the results have been compared with each other. Numerical studies for calculating activation parameters related to the COOH mechanism show higher values than those related to the COCl mechanism and therefore COOH mechanism can be suitable for noncovalent functionalization. These results could be generalized to other similar drugs.
https://www.chemrevlett.com/article_104171_f66fb1ab50f6e94149cc133271c64e1c.pdf
2020-01-01
23
37
10.22034/crl.2020.221149.1039
Density functional theory
Flutamide drug
Functionalized carbon nanotubes
Covalent and noncovalent functionalization
Reaction mechanisms
Maedeh
Kamel
kamel.chemist@gmail.com
1
Department of Chemistry, Payame Noor University, Tehran, Iran
LEAD_AUTHOR
Ali
Morsali
almorsali@yahoo.com
2
Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, Iran
AUTHOR
Heidar
Raissi
hraissy@yahoo.com
3
Department of Chemistry, University of Birjand, Birjand, Iran
AUTHOR
Kamal
Mohammadifard
ka_mfcheng@yahoo.com
4
Department of chemical engineering, Ferdowsi University of Mashhad, Mashhad, Iran
AUTHOR
1] S. Iiima and T. Ichihashi, Single-shell carbon nanotubes of 1-nm diameter. Nature., 363 (1993) 603-605.
1
[2] V. Derycke, R. Martel, J. Appenzeller and Ph. Avouris, Controlling doping and carrier inection in carbon nanotube transistors Appl. Phys. Lett., 80 (2002) 2773-2775.
2
[3] P.M. Alderton and J. Gross, Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res., 52 (1992) 194–201
3
[4] Z. Mahdavifar and R. Moridzadeh, Theoretical prediction of encapsulation and adsorption of platinum-anticancer drugs into single walled boron nitride and carbon nanotubes. Incl. Phenom. Macrocycl. Chem., 79 (2014) 443–457.
4
[5] R. Wang and D. Zhang, Theoretical Study of the Adsorption of Carbon Monoxide on Pristine and silicon-doped Boron Nitride
5
Nanotubes. Aust. Chem., 61 (2009) 941–945.
6
[6] D. Pantarotto, P. Briand, M. Prato and A. Bianco, Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chem. Commun., 1 (2004) 16-17.
7
[7] B. Ttrzaskowski, A.F. albout and L. Adamowicz, Molecular dynamics studies of protein-fragment models encapsulated into carbon nanotubes. Chem. Phys. Lett., 430 (2006) 97-100.
8
[8] D. Pantarotto, C.D. Partidos and J. Hoebeke, Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem. Biol., 10 (2003) 961–966.
9
[9] R. Singh, D. Pantarotto and D. McCarthy, Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotubebased gene delivery vectors. Am. Chem. Soc., 127 (2005) 4388–4396.
10
[10] M. Prato, K. Kostarelos and A. Bianco, Functionalized carbon nanotubes in drug design and discovery. Acc. Chem. Res., 41 (2007) 60–68.
11
[11] A. Bianco, K. Kostarelos, C.D. Partidos and M. Prato, Biomedical applications of functionalized carbon nanotubes. Chem. Commun., 5 (2005) 571–577.
12
[12] A. Saberinasab, H. Raissi and H. Hashemzadeh, Understanding the Effect of Vitamin B6 and PEG Functionalization on Improving the Performance of Carbon Nanotubes in Temozolomide Anticancer Drug Transportation. J. Phys. D. Appl. Phys., 52 (2019).
13
[13] N. Saikia, R.C. Deka, Theoretical study on pyrazinamide adsorption onto covalently functionalized (5, 5) metallic single-walled carbon nanotube. Chem. Phys. Lett., 2010, 500, 65–70.
14
[14] H. Shaki, H. Raissi, F. Mollania and H. Hashemzadeh, Modeling the interaction between anti-cancer drug penicillamine and pristine and functionalized carbon nanotubes for medical applications: density functional theory investigation and a molecular dynamics simulation. J. Biomol. Struct. Dyn., (2019) 1–13
15
[15] N.W.S. Kam and H. Dai, Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J. Am. Chem. Soc., 127 (2005) 6021–6026.
16
[16] M. Gallo, A. Favila and D.G. Mitnik, DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chem. Phys. Lett., 447 (2007) 105–109.
17
[17] K. Aima, M. Yudasaka and T. Murakami, Carbon Nanohorns as Anticancer Drug Carriers. Mol. Pharm., 2 (2005) 475–480.
18
[18] H. Chegini, A. Morsali, M.R. Bozorgmehr and S.A. Beyramabadi, Theoretical study on the mechanism of covalent bonding of dapsone onto functionalised carbon nanotubes: effects of coupling agent. Prog. React. Kinet. Mech., 41 (2016) 345–355.
19
[19] F. Labrie, Mechanism of action and pure antiandrogenic properties of flutamide. Cancer., 72 (1993) 3816–3827.
20
[20] C.P. Firme and P.R. Bandaru, Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed. Nanotechnol. Biol. Med., 6 (2010) 245–256.
21
[21] T. Tsuneda, J.W. Song, S. Suzuki and K. Hirao, On Koopmans’ theorem in density functional theory. J. Chem. Phys., 133 (2010) 174101.
22
[22] T. Koopmans, About the assignment of wave functions and eigenvalues to the individual electrons of an atom. Physica., 1 (1934) 104–113.
23
[23] A.D. Becke, Density‐functional thermochemistry. III. The role of exact exchange. J. Chem. Phys., 98 (1993) 5648–5652.
24
[24] C. Lee, W. Yang and R.G. Parr, Development of the Colle-Salvetti correlation- energy formula into a functional of the electron density. Phys. Rev. B., 37 (1988) 785.
25
[25] M Frisch, G.W. Trucks, H.b. Schlegel, et al., Gaussian Inc,
26
Wallingford, CT (2004).
27
[26] A. Morsali, Mechanism of the Formation of Palladium(II) Maleate Complex: A DFT Approach, Int. . Chem. Kinet., 47 (2015) 73–81.
28
[27] J. Tomasi and M. Persico, Molecular interactions in solution: an overview of methods based on continuous distributions of the solvent. Chem. Rev., 94 (1994) 2027–2094.
29
[28] M. Zaboli and H. Raissi, A combined molecular dynamics simulation and quantummechanics study on mercaptopurine interaction with the cucurbit[6,7] urils: Analysis of electronic structure. Spectrochim. Acta. Part A. Mol. Biomol. Spectrosc., 188 (2018) 647–658.
30
[29] A.E. Reed, J.E. Carpenter and F. Wienhold, NBO version 3.1. Gaussian. Inc Pittsburgh (1992).
31
[30] F. Biegler-König and J. Schönbohm, AIM2000- A Program to Analyze and Visualize Atoms in Molecules. J. Comput. Chem., 23 (2002) 1489–1494.
32
[31] D. Yildiz and U. Bozkaya, Assessment of the extended Koopmans' theorem for the chemical reactivity: accurate computations of chemical potentials, chemical hardnesses and electrophilicity indices. J. Comput. Chem., 37 (2016) 345–353.
33
[32] R.G. Pearson, Absolute Electronegativity and Hardness: Application to Inorganic Chemistry. Inorg. Chem., 27 (1988) 734–740.
34
[33] P. Bagaria, S. Saha, S. Murru, et al., A comprehensive decomposition analysis of stabilization energy (CDASE) and its application in locating the ratedetermining step of multi-step reactions. Phys. Chem. Chem. Phys., 11 (2009) 8306–8315.
35
[34] A. Sarmah and R.K. Roy, Understanding the interaction of nucleobases with chiral semiconducting single-walled carbon nanotubes: an alternative theoretical approach based on density functional reactivity theory. J. Phys. Chem. C., 117 (2013) 21539–21550.
36
[35] N.M. O’boyle, A.L. Tenderholt and K.M. Langner, a library for packageindependent computational chemistry algorithms. . Comput. Chem., 29 (2008) 839–845.
37
[36] M. Kamel, H. Raissi and A. Morsali, Theoretical study of solvent and co-solvent effects on the interaction of Flutamide anticancer drug with Carbon nanotube as a drug delivery system. J. Mol. Liq., 248 (2017) 490-500.
38
[37] M. Shahabi and H. Raissi, Assessment of solvent effects on the inclusion behavior of pyrazinamide drug into cyclic peptide based nanotubes as novel drug delivery vehicles. J. Mol. Liq., 268 (2018) 326–334.
39
[38] M. Kamel, H. Raissi, A. Morsali and K. Mohammadifard, Density functional theory study towards investigating the adsorption properties of the γ-Fe2O3 nanoparticles as a nanocarrier for delivery of Flutamide anticancer drug. Adsorption., (2019) 1–15.
40
[39] I. Rozas, I. Alkorta and J. Elguero, Behavior of ylides containing N, O, and C atoms as hydrogen bond acceptors. J. Am. Chem. Soc., 122 (2000) 11154–11161.
41
[40] E. Espinosa and E. Molins, Retrieving interaction potentials from the topology of the electron density distribution: the case of hydrogen bonds. J. Chem. Phys., 113 (2000) 5686–5694.
42
[41] E. Espinosa, M. Souhassou, H. Lachekar and C. Lecomte, Topological analysis of the electron density in hydrogen bonds. Acta. Crystallogr. Sect. B. Struct. Sci., 55 (1999) 563–572.
43
[42] J. Contreras-Garc, ER. ohnson, S. Keinan, et al., NCIPLOT: a program for plotting non-covalent interaction regions. J. Chem. Theory. Comput., 7 (2011) 625–632.
44
[43] H. Hashemzadeh and H. Raissi, Covalent Organic Framework
45
as Smart and High Efficient Carrier for Anticancer Drug Delivery: A DFT Calculations and Molecular Dynamics Simulation Study. J. Phys. D. Appl. Phys., 51 (2018) 345401.
46
[44] M. Hesabi and R. Behatmanesh-Ardakani, Investigation of Carboxylation of Carbon Nanotube in the Adsorption of Anti-
47
cancer Drug: A theoretical approach. Appl. Surf. Sci., 427 (2018) 112–125.
48
[45] C. Xiong and C. Yao, Adsorption Behavior of MWAR Toward Gd(III) in Aqueous Solution. Iran. J. Chem. Chem. Eng., 29 (2010) 59–66.
49
ORIGINAL_ARTICLE
An overview on the green petroleum production
Given the greenhouse gas emissions and future biofuels control, it is encouraged to look for alternatives to raw materials and green granular processes in the crop to produce these biodegradable chemicals. In addition, bio-oil or disinfectant crop oil for the production of second-generation biofuels, bio-oil can be processed in various refining units and may also result in green diesel production, which is not only an opportunity but also an opportunity. It's a challenge for the oil industry. Green Oil or Diesel Green can be produced by renewable diesel processing with petroleum oil in the current hydroprocessing unit. Hoping to discover the mechanism and optimization of processing technology by adding quantities of oils and animal fats to the traditional oil refining process, much research and work has been done on the processing process and simultaneous processing processes. Green Oil This is a literature review of green oil production using hydroprocessing and concurrent processing.
https://www.chemrevlett.com/article_104433_055bc5eab456d2cd612859d3f7df2a9a.pdf
2020-01-01
38
52
10.22034/crl.2020.222515.1041
Green Petroleum
Biofuel
Hydroprocessing
Hydrocracking
Biodiesel
Bioenergy
Nima
Norouzi
nima1376@aut.ac.ir
1
Department of Energy, Amirkabir university of technology, Tehran, Iran
LEAD_AUTHOR
Saeed
Talebi
satalebi@aut.ac.ir
2
Assistant Professor, Department of Energy, Amirkabir university of technology, Tehran, Iran
AUTHOR
[1]. B. Kamm, P. R. Gruber and M. Kamm, “Biorefinery In-dustrial Processes and Products: Status and Future Direc-tion,” Vol. 1-2, Wiley-Verlay Gmbtt and Co. KGaA, Weinheim, (2006).
1
[2]. C. V. Stevens and R. Verhe, “Renewable Bioresources Scope and Modification for Non-Food Application,” John
2
Wiley and Sons Ltd., England, (2004).
3
[3]. D. Puppan, “Environmental Evaluation of Biofuels,” Period Polytechnica, Vol. 10, No. 1, (2002), pp. 95-116.
4
[4]. K. S. Tyson, “Biodiesel Handling and Use Guidelines,” National Renewable Energy Laboratory, Golden, (2001), p. 22.
5
[5]. J. L. Shumaker, C. Crofcheck, S. A. Tackett, E. Santillan- Jimenez and M. Crocker; Biodiesel Production from Soybean Oil Using Calcined Li-Al Layered Double Hy-droxide Catalysts. Catal. Lett., 115 (2007) 56-61.
6
[6]. J. Holmgren, “Biofuels: Unlocking the Potential,” ERTC 12th Annual Meeting, Barcelona, 19-21 November, (2007).
7
[7]. N. Eisberg, Harvesting Energy. Chem. Ind., No. 17, (2006), pp. 24-25.
8
[8]. European Commission (EC), “Promoting Biofuels in Europe,” Directorate-General for Energy and Transport, Bruxelles, (2004), B-1049.
9
[9]. Meet Clean Diesel, “Renewable Diesel Fuels”. http://www.dieselforum.org
10
[10]. G. Knothe, Biodiesel and Renewable Diesel: A Com-parison. Prog. Energy. Combust. Sci., 36 (2010) 364-373.
11
[11]. O. i. Şenol, T.-R. Viljava and A. O. I. Krause, Hydro-deoxygenation of Aliphatic Esters on Sulphided Ni-MO/γ-Al2O3 and CoMo/γ-Al2O3 Catalyst: The Effect of Water. Catal. Today., 106 (2005) 186-189.
12
[12]. O. i. Şenol, E.-M. Ryymin, T.-R. Viljava and A. O. I. Krause, Reactions of Methyl Heptanoate Hydrodeoxy-genation on Sulphided Catalysts. J. Mol. Catal. A. Chem., 268 (2007) 1-8.
13
[13]. O. i. Şenol, E.-M. Ryymin, T.-R. Viljava and A. O. I. Krause, Effect of Hydrogen Sulphide on the Hydrode-oxygenation of Aromatic and Aliphatic Oxygenates on Sulphided Catalysts. J. Mol. Catal. A. Chem., 277 (2007).
14
[14]. S. Bezergianni, A. Kalogianni and I. A. Vasalos, Hydro-cracking of Vacuum Gas Oil-Vegetable Oil Mixtures for Biofuels Production. Bioresour. Technol., 100 (2009) 3036-3042.
15
[15]. M. Ferrari, S. Bosmans, R. Maggi, B. Delmon and P. Grange, CoMo/Carbon Hydrodeoxygenation Catalysts: Influence of the Hydrogen Sulfide Partial Pressure and of the Sulfidation Temperature. Catal. Today., 65 (2001) 257-264.
16
[16]. M. Ferrari, R. Maggi, B. Delmon and P. Grange, Influ-ences of the Hydrogen Sulfide Partial Pressure and of a Nitrogen Compound on the Hydrodeoxygenation Activity of a CoMo/Carbon Catalyst. J. Catal., 198 (2001) 47-55.
17
[17]. G. de la Puente, A. Gil, J. J. Pis and P. Grange, Effects of Support Surface Chemistry in Hydrodeoxygenation Reactions over CoMo/Activated Carbon Sulfided Cata-lysts. Langmuir., 15 (1999) 5800-5806.
18
[18]. J. Gusmaäo, D. Brodzki, G. Djéga-Mariadassou and R. Frety, Utilization of Vegetable Oils as an Alternative Source for Dieseltype Fuel: Hydrocracking on Educed Ni/SiO2 and Sulfided Ni-Mo/γ-Al2O3. Catal. Today., 4 (1989) 533-544.
19
[19]. W. F. Maier, W. Roth, I. Thies and P. V. Ragué Schleyer, Hydrogenolysis, IV. Gas Phase Decarboxylation of Car-boxylic Acids. Chem. Ber., 115 (1982) 808-812.
20
[20]. P. Mäki-Arvela, I. Kubičkova, M. Snare, K. Eränen and D. Y. Murzin, Catalytic Deoxygenation of Fatty Acids and Their Derivatives. Energy. Fuel., 21 (2007) 30-41.
21
[21]. M. Snare, I. Kubičkova, P. Mäki-Arvela, D. Chichova, K. Eränen and D. Y. Murzin, Catalytic Deoxygenation of Unsaturated Renewable Feedstocks for Roduction of Diesel Fuel Hydrocarbons. Fuel., 87 (2008) 933-945.
22
[22]. P. P. Nunes, D. Brodzki, G. Bugli, G. Djega-Mariadassou, Soybean Oil Hydrocracking under Pressure: Process and General Aspect of the Transformation. Rev.
23
Inst. Franç. Pétrole., 41 (1986) 421-431.
24
[23]. M. E. Halttunena, M. K. Niemeläa, A. O. I. Krausea and A. I. Vuori, Rh/C Catalysts for Methanol Hydrocarbon-ylation. II. Activity in the Presence of MeI. Appl. Catal. A. Gen., 182 (1999) 115-123.
25
[24]. M. Snare, I. Kubičková, P. Mäki-Arvela, K. Eränen, J. Wärna, D. Y. Murzin, Heterogeneous Catalytic Deoxy-genation of Stearic Acid for Production of Biodiesel. Ind. Eng. Chem. Res., 45 (2006) 5708-5715.
26
[25]. G. W. Huber and A. Corma, Synergies between Bio- and Oil Refineries for the Production of Fuels from Biomass. Angew. Chem. Int. Ed., 46 (2007) 7184-7201.
27
[26]. L. Reijnders, Conditions for the Sustainability of Bio-mass Based Fuel Use. Energ. Policy., 34 (2006) 863-876.
28
[27]. L. C. Meher, D. V. Sagar and S. N. Naik, Technical Aspects of Biodiesel Production by Transesterification— A Review. Renew. Sust. Energ. Rev., 10 (2006) 248-268.
29
[28]. C. Difiglio, Using Advanced Technologies to Reduce Motor Vehicle Greenhouse Gas Emissions. Energ. Policy., 25 (1997) 1173-1178.
30
[29]. J. H. Marsman, J. Wildschut, F. Mahfud and H. J. Heeres, Identification of Components in Fast Pyrolysis Oil and Upgraded Products by Comprehensive Two-Dimensional Gas Chromatography and Flame Ionisation Detection. J. Chromat. A., 1150 (2007) 21-27.
31
[30]. J. H. Marsman, J. Wildschut, P. Evers, S. de Koning and H. J. Heeres, Identification and Classification of Com-ponents in Flash Pyrolysis Oil and Hydrodeoxygenated Oils by Two-Dimensional Gas Chromatography and Time- of-Flight Mass Spectrometry. J. Chromat. A., 1188 (2008) 17-25.
32
[31]. F. de Miguel Mercader, M. J. Groeneveld, S. R. A. Ker-sten, N. W. J. Way, C. J. Schaverien and J. A. Hogen-doorn, Production of Advanced Biofuels: Co-Processing of Upgraded Pyrolysis Oil in Standard Refinery Units. Appl. Catal. B. Environ., 96 (2010) 57-66.
33
[32]. J. D. Rocha, C. A. Luengo and C. E. Snape, Hydro- dexygenation of Oils from Ceelulose in Single and Two- Stage Hydripyrolysis. Renew. Energ., 9 (1996) 950-953.
34
[33]. P. Grange, E. Laurent, R. Maggi, A. Centeno and B. Del-mon, Hydrotreatment of Pyrolysis Oils from Biomass: Reactivity of the Various Categories of Oxygenated Com- pounds and Preliminary Techno-Economical study. Catal. Today., 29 (1996) 297-301.
35
[34]. S. P. Zhang, Y. Yongjie, T. Li, et al. Upgrading of Liq-uid Fuel from the Pyrolysis of Biomass. Bioresour. Technol., 96 (2005) 545-550.
36
[35]. Y. Xu, T. Wang, L. Ma, Q. Zhang and L. Wang, Up-grading of Liquid Fuel from the Vacuum Pyrolysis of Biomass over the Mo-Ni/γ-Al2O3 Catalysts. Biomass. Bioenerg., 33 (2009) 1030-1036.
37
[36]. Y. Xu, T. Wang, L. Ma, Q. Zhang and W. Liang, Up-grading of the Liquid Fuel from Fast Pyrolysis of Bio-mass over MoNi/γ-Al2O3 Catalysts. Appl. Energ., 87 (2010) 2886-2891.
38
[37]. J. Wildschut, I. Melián-Cabrera and H. J. Heeres, Cata-lyst Studies on the Hydrotreatment of Fast Pyrolysis Oil. Appl. Catal. B. Environ., 99 (2010) 298-306.
39
[38]. M. Stumborg, A. Wong and E. Hogan, Hydroprocessed Vegetable Oils for Diesel Fuel Improvements. Bioresour. Technol., 56 (1996) 13-18.
40
[39]. L. Avaullée, P. Duchet-Suchaux, M. Durandeu and J. N. Jaubert, A New Approach in Correlating the Oil Ther-modynamic Properties. J. Petrol. Sci. Eng., 30 (2001) 43-65.
41
[40]. C. Fragale, M. Gargano, N. Ravasio, M. Rossi and I. Santo, Catalytic Hydrogenation of Vegetable Oils: III. A Comparison of Reactivity and Selectivity between Cyclic Polyenes and Polyunsaturated Fatty Acids with Copper Chromite as Catalyst. Inorg. Chim. Acta., 82 (1984) 157-160.
42
[41]. J. S. Milano-Brusco and R. Schomäcker, Catalytic Hy-drogenations in Microemulsion Systems with Rh-TPPTS: Partial Hydrogenation of Sunflower Oil. Catal. Lett., 133, (2009) 273-279.
43
[42]. Ullmann, “Ullmann’s Encyclopedia of Industrial Chemis-try,” Vol. 13, Wiley-VCH Verlag GmbH & Co., Wein-heim, (2003).
44
[43]. R. C. Christiansen, Neste Oil Building Singapore Re-newable Diesel Plant. Biodiesel Magazine, March (2009). http://www.biodieselmagazine.com/article.
45
[44]. Schill, S.R. JAL flight to test camelina-jatropha-algae fuel. Biodiesel Magazine, January (2008). http://www.biodieselmagazine.com/article
46
[45]. J. L. Harwood and F. D. Gunstone, Occurrence and char-acterisation of oils and fats,” In: F. D. Gunstone, J. L. Harwood and J. L. Dijkstra, Eds., The Lipid Handbook, CRC Press, Boca. Raton., (2007) 37-141.
47
[46]. Q. Hu, M. Sommerfeld, E. Jarvis, M. Ghirardi, M, Pose-witz, M. Seibert, et al., Microalgal Triacylglycerols as Feedstocks for Biofuel Production: Erspectives and Ad-vances. Plant. J., 54, (2008) 621-639.
48
[47]. J. L. Guil-Guerrero, F. Gómez-Mercado, F. García-Marotoc and P. Campra-Madrida, Occurrence and Characterization of Oils Rich in γ-Linolenic Acid: Part I: Echium Seeds from Macaronesia. Phytochem., 53 (2000) 451-456.
49
[48]. D. Kubička, J. Chudoba, P. Šimaček, “Europacat VIII,” Turku, 26-31 August (2007).
50
[49]. N. Zeman, “Neste Oil Starts Construction on Europe’s Largest Renewable Fuels Plant,” Biodiesel Magazine, May (2009). http://www.biodieselmagazine.com/article
51
[50]. M. Izadifar and M. Z. Jahromi, “Application of Genetic Algorithm for Optimization of Vegetable Oil Hydrogena-tion Process. J. Food. Eng., 78 (2007) 1-8.
52
[51]. G. N. da Rocha Filho, D. Brodzki and G. Djéga-Ma- riadassou Formation of Alkanes, Alkylcycloalkanes and Alkylbenzenes during the Catalytic Hydrocracking of Ve- getable Oils, Fuel., 72 (1993) 543-549.
53
[52]. D. Kubička and L. Kaluža, Deoxygenation of Vegetable Oils over Sulfided Ni, Mo and NiMo Catalysts. Appl. Catal. A. Gene., 372 (2010) 199-208.
54
[53]. P. Šimáček, D. Kubička, G. Šebor and M. Pospíšil, Fuel Properties of Hydroprocessed Rapeseed Oil. Fuel., 89 (2010) 611-615.
55
[54]. P. Šimáček, D. Kubička, G. Šebor and M. Pospíšil, Hy-droprocessed Rapeseed Oil as a Source of Hydrocar-bon-Based Biodiesel. Fuel., 88 (2009) 456-460.
56
[55]. P. Šimaček and D. Kubičk, Hydrocracking of Petroleum Vacuum Distillate Containing Rapeseed Oil: Evaluation of Diesel Fuel. Fuel., 89 (2010) 1508-1513.
57
[56]. K. C. Kwon, H. Mayfield, T. Marolla, B. Nichols and M. Mashburn, Catalytic Deoxygenation of Liquid Biomass
58
[57]. for Hydrocarbon Fuels. Renew. Energ., 36 (2011) 907-915.
59
[58]. J. Monniera, H. Sulimmab, A. Dalaib and G. Caravaggio, Hydrodeoxygenation of Oleic Acid and Canola Oil over Alumina-Supported Metal Nitrides. Appl. Catal. A. Gen., 382 (2010) 176-180.
60
[59]. O. V. Kikhtyanin, A. E. Rubanov, A. B. Ayupov and G. V. Echevsky, Hydroconversion of Sunflower Oil on Pd/SAPO-31 Catalyst. Fuel., 89 (2010) 3085-3092.
61
[60]. J. Hancsók, M. Krár, S. Magyar, L. Boda, A. Holló and D. Kalló, Investigation of the Production of High Cetane Number Bio Gas Oil from Pre-Hydrogenated Vegetable Oils over Pt/HZSM-22/Al2O3. Microporous. Mesoporous. Mater., 101 (2007) 148-152.
62
[61]. D. Kubička and J. Hoŕácek, Deactivation of HDS Cata-lysts in Deoxygenation of Vegetable Oils. Appl. Catal. A. Gene., 394 (2010) 9-17.
63
[62]. E. Furimsky, Chemistry of Catalytic Hydrogenation. Catal. Rev. Sci. Eng., 25 (1983) 421-458.
64
[63]. E. Dorrestijn and P. Mulder, The Radical-Induced De-composition of 2-Methoxyphenol. J. Chem. Soc., 2 (1999) 777-780.
65
[64]. G. N. da Rocha Filho, D. Brodzki and G. Djéga-Mariadassou, Formation of Alkanes, Alkylcycloalkanes and Alkyl-benzenes during the Catalytic Hydrocracking of Vegeta-ble Oils. Fuel., 72 (1993) 543-549.
66
[65]. S. Echeandia, P. L. Arias, V. L. Barrio, B. Pawelec and J. L. G. Fierro, Synergy Effect in the HDO of Phenol Over Ni-W Catalysts Supported on Active Carbon: Effect of Tungsten Precursors. Appl. Catal. B. Environ., 101 (2010) 1-12.
67
[66]. L. Boda, G. Onyestyák, H. Solt, F. Lónyi, J. Valyon and A. Thernesz, Catalytic Hydroconversion of Tricaprylin and Caprylic Acid as Model Reaction for Biofuel Produc-tion from Triglycerides. Appl. Catal. A. Gene., 374 (2012) 158-169.
68
[67]. Kubičková, M. Snare, K. Eränen, P. Mäki-Arvela and D.Y. Murzin, Hydrocarbons for Diesel Fuel via Decar-boxylation of Vegetable Oils. Catal. Today., 106 (2005) 197-200.
69
[68]. Q. Smejkala, L. Smejkalováa and D. Kubičkab, Ther-modynamic Balance in Reaction System of Total Vegeta-ble Oil Hydrogenation. Chem. Eng. J., 146 (2009) 155-160.
70
[69]. S. Vitu, R. Privat, J. N. Jaubert and F. Mutelet, Predict-ing the Phase Equilibria of CO2 + Hydrocarbon Systems with the PPR78 Model (PR EOS and kij Calculated through a Group Contribution Method). J. Supercrit. Fluids., 45 (2008) 1-26.
71
[70]. G. Joback, A Unified Approach to Physical Property Estimation Using Multivariate Statistical Techniques. Master’s Thesis, MIT, Cambridge, (1984).
72
[71]. Q. Smejkala, L. Smejkalová and D. Kubička, Thermo-dynamic Balance in Reaction System of Total Vegetable Oil Hydrogenation. Chem. Eng. J., 146 (2009) 155-160.
73
[72]. E. Laurent and B. Delmon. Study of the Hydrodeoxy-genation of Carbonyl, Carboxylic and Guaiacyl Groups over Sulfided CoMo/γ-Al2O3 and NiMo/γ-Al2O3 Catalysts: II. Influence of Water, Ammonia and Hydrogen Sulfide. Appl. Catal. A. Gen., 109 (1994) 97-115.
74
[73]. O. I. Şenol, T.-R. Viljava and A. O. I. Krause, Effect of Sulphiding Agents on the Hydrodeoxygenation of Ali-phatic Esters on Sulphided Catalysts. Appl. Catal. A. Gen., 326 (2007) 236-244.
75
[74]. V. N. Bui, G. Toussaint, D. Laurenti, C. Mirodatos and C. Geantet, Co-Processing of Pyrolisis Bio Oils and Gas Oil for New Generation of Bio-Fuels: Hydrodeoxygena-tion of Guaïacol and SRGO Mixed Feed. Catal. Today., 143 (2009) 172-178.
76
[75]. O. İ. Şenol, T.-R. Viljava and A. O. I. Krausede, Hydro-deoxygenation of Methyl Esters on Sulphided NiMO/γ- Al2O3 and CoMo/γ-Al2O3 catalysts. Catal. Today., 100 (2005) 331-335.
77
[76]. Sebos, A. Matsoukas, V. Apostolopoulos and N. Pa-payannakos, Catalytic Hydroprocessing of Cottonseed Oil in Petroleum Diesel Mixtures for Production of Re-newable Diesel. Fuel., 88 (2009) 145-149.
78
[77]. Walendziewski, M. Stolarski, R. Łużny and B. Klimek, Hydroprocesssing of Light Gas Oil—Rape Oil Mixtures. Fuel. Process. Technol., 90 (2009) 686-691.
79
[78]. G. W. Huber, P. ƠConnor and A. Corma, Processing Biomass in Conventional Oil Refineries: Production of High Quality Diesel by Hydrotreating Vegetable Oils in Heavy Vacuum Oil Mixtures. Appl. Catal. A. Gene., 329 (2007) 120-129.
80
[79]. F. Z. Benhachem; T. A.; Fouzia Bouabdallah. Kinetic study of adsorption methylene blue dye from aqueous solutions using activated carbon. Chem. Rev. Lett., 2 (2019) 33-39.
81
[80]. S. Sarhandi., Z. Rahmani., R. Moghadami, M. Vali, E. Vessally. New insight in Hiyama cross-coupling reactions: Decarboxylative, denitrogenative and desulfidative couplings. Chem. Rev. Lett., 1 (2018) 9-15.
82
[81]. F. Valinia; N. Shojaei; P. Ojaghloo. Novel 1-(4-chlorophenyl)-3-(2-ethoxyphenyl)triazene ligand: Synthesis, X-ray crystallographic studies, spectroscopic characterization and DFT calculations. Chem. Rev. Lett., 2 (2019) 90-97.
83
[82]. S. A. Siadati; K Kula; E. Babanezhad. The possibility of a two-step oxidation of the surface of C20 fullerene by a single molecule of nitric (V) acid. Chem. Rev. Lett., 2 (2019) 2-6.
84
[83]. F. Krika; A. Krika; A. Azizi. Arundo donax L. as a low-cost and promising biosorbent for the removal of crystal violet from aqueous media: kinetic, isotherm and thermodynamic investigations. Chem. Rev. Lett., 2 (2019) 59-68.
85
[84]. S. Majedi; H. G. Rauf; M. Boustanbakhsh. DFT study on sensing possibility of the pristine and Al- and Ga-embeded B12N12 nanostructures toward hydrazine and hydrogen peroxide and their analogues. Chem. Rev. Lett., 2 (2019) 176-186.
86
[85]. R. Kakulvand. The effects of transient heat flux on the tube in contact with the natural convection, on enthalpy and entropy generation, for developed laminar flow of fluid with high Prandtl number. Chem. Rev. Lett., 2 (2019) 165-175.
87
[86]. D. E. Arthur; A. A. Oyibo; S. N. Adawara; S. Hassan; E. Uwaiya. Miscibility study of poly acrylamide (PAM) and Acacia Senegal (gum arabic) blends. Chem. Rev. Lett., 2 (2019) 157-164.
88
[87]. E. A. Mahmood; B. Azizi; S. Majedi. Decarboxylative cyanation and azidation of carboxylic acids: An overview. Chem. Rev. Lett., 3 (2020) 2-8.
89
R. Moladoust. Sensing performance of boron nitride nanosheets to a toxic gas cyanogen chloride: Computational exploring. Chem. Rev. Lett., 2 (2019) 151-156.
90
[88]. C. Mustapha; D. Benamar. Comparison of the bromate ions removal by nanofiltration membranes made from different polymers at different conditions. Chem. Rev. Lett., 2 (2019) 118-122.
91
[89]. M. Nikpassand; Leila Zare Fekri. Synthesis of bis coumarinyl methanes using of potassium 2-oxoimidazolidine-1,3-diide as a novel, efficient and reusable catalyst. Chem. Rev. Lett., 2 (2019) 7-12.
92
[90]. A. O. Gezerman. Effects of ammonium thiosulfate and guanyl thiourea as calcium ammonium nitrate inhibitors on fertilization and plants. Chem. Rev. Lett., 2 (2019) 84-89.
93
[91]. N. Norouzi, M. Fani, Z. K. Ziarani, The fall of oil Age:A scenario planning approach over the last peak oil of human history by 2040, Journal of Petroleum Science and Engineering, Volume 188, (2020), 106827, ISSN 0920-4105.
94
[92]. F. B.; Z. Asadi; Y. J. Sadeghi. Synthesis, spectroscopic and computational investigation of bis (3-methoxyphenylthio) ethyl) naphthalene. Chem. Rev. Lett., 1 (2018) 68-76.
95
[93]. F. Gharibzadeh; S. Gohari; K. Nejati; B. Hashemzadeh;
96
S. Mohammadiyan. The Be atom doping: An effective way to improve the Li-atom adsorption in boron rich nanoflake of B24. Chem. Rev. Lett., 1 (2018) 16-22.
97
[94]. E. Babanezhad; A. Beheshti. The Possibility of Selective Sensing of the Straight-Chain Alcohols (Including
98
Methanol to n-Pentanol) Using the C20 Fullerene and C18NB Nano Cage. Chem. Rev. Lett., 1 (2018) 82-88.
99
[95]. M. H. N. Janjanpour; M. Vakili; S. Daneshmehr; K. Jalalierad; F. Alipour. Study of the Ionization Potential, Electron Affinity and HOMO-LUMO Gaps in the Smal Fullerene Nanostructures. Chem. Rev. Lett., 1 (2018) 45-48.
100